Edgar Adrian Castellanos1, Susan Noworolski2, Diana Alba3, Peter Hunt3, and Suneil Koliwad3
1Department of Radiology and Biomedical Imaging, University of California , San Francisco, San Francisco, CA, United States, 2Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States, 3Department of Medicine and Diabetes Center, University of California, San Francisco, San Francisco, CA, United States
1Department of Radiology and Biomedical Imaging, University of California , San Francisco, San Francisco, CA, United States, 2Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States, 3Department of Medicine and Diabetes Center, University of California, San Francisco, San Francisco, CA, United States
Pancreatic fat fraction measures were higher in those with high HOMA-IR versus low in a HIV+ cohort, but not in controls.
Figure 1 Pancreatic fat fraction in high (>2.2ml/mU) HOMA-IR (n=8) and low (<2.2 mmol/mU) HOMA-IR (n=8) in the HIV- cohort.
Pancreatic fat fraction in high (>2.2ml/mU) HOMA-IR (n=6) and low (<2.2 mmol/mU) HOMA-IR (n=10) in the cohort with HIV+.
